2017-05-03
The impact of HPV vaccination on HPV and cervical cancer in the Netherlands
Publication
Publication
Human papillomavirus (HPV) is a highly prevalent sexually transmitted virus, of which 150 types have been completely sequenced. Currently, about 14 HPV-types are considered ‘high risk’ for their potential to cause cervical cancer, the fourth most common cancer among women worldwide. In particular HPV-16 and HPV-18 are predominantly present in precancerous lesions and invasive cervical cancer. Luckily, vaccines have been developed to protect against these HPV-types. This thesis includes modeling studies in which we explore the role of naturally acquired immunity after clearing an HPV-16 and HPV-18 infection in the spread of HPV, as well as the impact of HPV vaccination on HPV and cervical cancer in the Netherlands.
| Additional Metadata | |
|---|---|
| , , , , , , | |
| H.J. de Koning (Harry) , S.J. de Vlas (Sake) | |
| Erasmus University Rotterdam | |
| hdl.handle.net/1765/98975 | |
| Organisation | Netherlands Institute for Health Science (NIHES) |
|
Matthijsse, S. (2017, May 3). The impact of HPV vaccination on HPV and cervical cancer in the Netherlands. Retrieved from http://hdl.handle.net/1765/98975 |
|
| Additional Files | |
|---|---|
| SuzetteMatthijsse.propositions.pdf , 84kb | |
| 4692_Matthijsse-Suzette-Maria.jpg Cover Image , 14kb | |
